FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971566387> ?p ?o ?g. }

• W1971566387 endingPage "671" @default.
• W1971566387 startingPage "667" @default.
• W1971566387 abstract "18F-FDG PET value for the assessment of neuroendocrine tumours (NET) is limited. Preliminary studies indicate that somatostatin receptor PET using 68Ga-DOTA-peptides is more accurate for disease assessment and provide additional data on receptor status, that are crucial for targeted radionuclide therapy. At present, however, few papers investigated the role of 68Ga-DOTA-NOC PET in NET, especially in unusual situations. The purpose of the present study was to evaluate 68Ga-DOTA-NOC for the evaluation of NET of uncommon presentation. Patients with biopsy-proven NET were scheduled for 68Ga-DOTA-NOC PET; we excluded from further evaluation cases with most common NET tumours (gastro-entero-pancreatic and pulmonary localization of primary lesion, MEN syndromes, medullary thyroid carcinoma, pheochromocytomas). PET results were compared with findings of conventional imaging, including CT, ultrasonography, MR and somatostatin receptor scintigraphy; finally PET results were compared with follow-up data with respect to the impact on patient management. Fourteen patients were finally enrolled; primary tumours were located at uterine level (3 cases), prostate (3 cases), ovary (1 case), kidney (1 case), breast (1 case), ear (1 case); also 3 cases of paraganglioma (at neck, abdominal and mediastinum level) and 1 case of lymphoma were included. 68Ga-DOTA-NOC PET was positive, showing at least 1 lesion, in 6/14 cases while 5 cases turned out negative and 2 inconclusive. On a clinical basis, 68Ga-DOTA-NOC provided additional information in comparison to conventional imaging procedures in 7/14 cases, and was considered useful in 12/14 patients, with 8 patients in which 68Ga-DOTA-NOC PET was determinant for patient's management. Although the number of patients studied is limited, our data show that 68Ga-DOTA-NOC can be usefully applied for the evaluation of NET of uncommon presentation; in particular very promising results were obtained in paraganglioma. On the other hand, care has to be paid when studying lesions localized at sites of physiological concentration of the tracer, and in presence of inflammation." @default.
• W1971566387 created "2016-06-24" @default.
• W1971566387 creator A5000034241 @default.
• W1971566387 creator A5003301205 @default.
• W1971566387 creator A5017414279 @default.
• W1971566387 creator A5019843160 @default.
• W1971566387 creator A5039994913 @default.
• W1971566387 creator A5045545320 @default.
• W1971566387 creator A5059462029 @default.
• W1971566387 creator A5060396380 @default.
• W1971566387 creator A5063023121 @default.
• W1971566387 creator A5076820936 @default.
• W1971566387 date "2008-12-01" @default.
• W1971566387 modified "2023-10-02" @default.
• W1971566387 title "Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET" @default.
• W1971566387 cites W1748597660 @default.
• W1971566387 cites W1968601682 @default.
• W1971566387 cites W1969294453 @default.
• W1971566387 cites W1973577894 @default.
• W1971566387 cites W1986723218 @default.
• W1971566387 cites W1990509102 @default.
• W1971566387 cites W1996931844 @default.
• W1971566387 cites W1998213676 @default.
• W1971566387 cites W2005741240 @default.
• W1971566387 cites W2009920299 @default.
• W1971566387 cites W2028805801 @default.
• W1971566387 cites W2047019936 @default.
• W1971566387 cites W2051636198 @default.
• W1971566387 cites W2052520415 @default.
• W1971566387 cites W2053825882 @default.
• W1971566387 cites W2059578957 @default.
• W1971566387 cites W2059777719 @default.
• W1971566387 cites W2074842142 @default.
• W1971566387 cites W2080916065 @default.
• W1971566387 cites W2088147866 @default.
• W1971566387 cites W2091231028 @default.
• W1971566387 cites W2095554730 @default.
• W1971566387 cites W2112838511 @default.
• W1971566387 cites W2140016891 @default.
• W1971566387 cites W2142974837 @default.
• W1971566387 cites W2150308149 @default.
• W1971566387 cites W2160684534 @default.
• W1971566387 cites W2171675963 @default.
• W1971566387 cites W2188250776 @default.
• W1971566387 cites W4244920031 @default.
• W1971566387 doi "https://doi.org/10.1016/j.biopha.2008.01.010" @default.
• W1971566387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18358680" @default.
• W1971566387 hasPublicationYear "2008" @default.
• W1971566387 type Work @default.
• W1971566387 sameAs 1971566387 @default.
• W1971566387 citedByCount "76" @default.
• W1971566387 countsByYear W19715663872012 @default.
• W1971566387 countsByYear W19715663872013 @default.
• W1971566387 countsByYear W19715663872014 @default.
• W1971566387 countsByYear W19715663872015 @default.
• W1971566387 countsByYear W19715663872017 @default.
• W1971566387 countsByYear W19715663872018 @default.
• W1971566387 countsByYear W19715663872019 @default.
• W1971566387 countsByYear W19715663872020 @default.
• W1971566387 countsByYear W19715663872021 @default.
• W1971566387 countsByYear W19715663872022 @default.
• W1971566387 countsByYear W19715663872023 @default.
• W1971566387 crossrefType "journal-article" @default.
• W1971566387 hasAuthorship W1971566387A5000034241 @default.
• W1971566387 hasAuthorship W1971566387A5003301205 @default.
• W1971566387 hasAuthorship W1971566387A5017414279 @default.
• W1971566387 hasAuthorship W1971566387A5019843160 @default.
• W1971566387 hasAuthorship W1971566387A5039994913 @default.
• W1971566387 hasAuthorship W1971566387A5045545320 @default.
• W1971566387 hasAuthorship W1971566387A5059462029 @default.
• W1971566387 hasAuthorship W1971566387A5060396380 @default.
• W1971566387 hasAuthorship W1971566387A5063023121 @default.
• W1971566387 hasAuthorship W1971566387A5076820936 @default.
• W1971566387 hasConcept C126322002 @default.
• W1971566387 hasConcept C126838900 @default.
• W1971566387 hasConcept C142724271 @default.
• W1971566387 hasConcept C150903083 @default.
• W1971566387 hasConcept C207001950 @default.
• W1971566387 hasConcept C2776297358 @default.
• W1971566387 hasConcept C2779066768 @default.
• W1971566387 hasConcept C2779931791 @default.
• W1971566387 hasConcept C2781156865 @default.
• W1971566387 hasConcept C2989005 @default.
• W1971566387 hasConcept C2993559085 @default.
• W1971566387 hasConcept C71924100 @default.
• W1971566387 hasConcept C80115893 @default.
• W1971566387 hasConcept C86803240 @default.
• W1971566387 hasConceptScore W1971566387C126322002 @default.
• W1971566387 hasConceptScore W1971566387C126838900 @default.
• W1971566387 hasConceptScore W1971566387C142724271 @default.
• W1971566387 hasConceptScore W1971566387C150903083 @default.
• W1971566387 hasConceptScore W1971566387C207001950 @default.
• W1971566387 hasConceptScore W1971566387C2776297358 @default.
• W1971566387 hasConceptScore W1971566387C2779066768 @default.
• W1971566387 hasConceptScore W1971566387C2779931791 @default.
• W1971566387 hasConceptScore W1971566387C2781156865 @default.
• W1971566387 hasConceptScore W1971566387C2989005 @default.
• W1971566387 hasConceptScore W1971566387C2993559085 @default.

• next